Cash and cash equivalents amounted to $69.8M as of September 30, compared to $32.5M as of December 31, 2024, a net increase of $37.4M. The company said, “The increase in Research tax credit during the three and the nine months ended September 30, 2025, is primarily due to the fact that more eligible activities have been carried out in the period, including the related costs of the FAREVA platform.”
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DBVT:
- DBV Technologies S.A. – American Depositary Shares (DBVT) Q3 Earnings Cheat Sheet
- Optimistic Outlook for DBV Technologies Amid Promising Viaskin Peanut Advancements
- DBV Technologies to sell $30M of ADSs through at-the-market program
- DBV Technologies Announces Board Member Resignation
- DBV Technologies Launches $150M ATM Equity Offering